* chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules...
TRANSCRIPT
![Page 1: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/1.jpg)
![Page 2: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/2.jpg)
* Chronic papulosqamous disease of unknown etiology
characterised by multiple erythematous papules & plaques
with micaceous scales mainly involving extensor aspect of
legs,elbows,lower buttocks,scalp due to accelerated
epidermopoiesis
In simple words,
* A Chronic (longlasting) skin disease characterized by
scaling and inflammation. Scaling occurs when cells in the
outer layer of skin reproduce faster than normal and pile
upon the skin’s surface
![Page 3: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/3.jpg)
• Genetic factors
- Autosomal dominant with incomplete penetrance.
- Increased prevalence of HLACw6.
- 9 locations on different chromosomes that are associated wit
psoriasis.
• Major determinant is PSORS1,which is located on chromosome 9 in
MHC.3genes in PSORS1 locus have a strong association with psoriasis
vulgaris.
• Environmental factors
![Page 4: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/4.jpg)
• About 1 to 2% of the U.S population or 5.5 million people get
infected.
• Mostly common between the age 15 to 35 years old.
• Mostly frequently occurs are male Caucasians population.
• It is also inherited
![Page 5: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/5.jpg)
* Stress
* Alcohol
* Drugs
- AntiHT(beta blockers)
- Lithium
- Antimalarials(chloroquine)
- NSAID's-(Aspirin,Ibuprofen)
* Infection
* Sunlight
* Climate
* Metabolic Factors like Pregnancy
* Trauma & surgery
![Page 6: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/6.jpg)
• Predominantly affects extensor aspects of extremities &
lumbosacral area of trunk
• Erythematous papules and plaques wit white micaceous scales
• Classically lesions demonstrate AUSPITZ sign
• Method of doing this test is called GRATTAGE Test
• +ve koebners phenomenon
• Associated nail & joint involvement
![Page 7: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/7.jpg)
Skin -> 1.Epidermis 2.Dermis 3.Hypodermis
•Skincells are created in the dermis and is moved to through the epidermis to the skin surface.
•Process takes 28-30 days
•In psoriasis patients hyperpoliferation takes place
•Transit time is shortened to 4-5 days, thus scales appear in the skin
![Page 8: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/8.jpg)
• Psoriasis vulgaris
• Guttate psoriasis
• Palmoplander psoriasis
• Flexular psoriasis
• Psoriatic arthrcpathy
• Erthrodermic psoriasis
• Psoriasis of nails
![Page 9: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/9.jpg)
According to the site of involvement it is specified as
• Scalp psoriasis
• Palmoplantar psoriasis
• Nail psoriasis
• Acropustolosis
![Page 10: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/10.jpg)
![Page 11: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/11.jpg)
![Page 12: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/12.jpg)
![Page 13: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/13.jpg)
• Hyperkeratosis
• Parakeratosis
• Acanthosis
• Papillomatosis
• Munromicroabscesses
• Suprapapillary thinnin of epidermis
![Page 14: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/14.jpg)
Clinical Features - Primary Test
Grettage test - Diagnosis
Biopsy - Confirmation
How severe
1. Mild -> affecting < 3% of skin
2. Moderate -> affecting 3-10% of skin
3. Severe -> depends on the
following • Proportion of body surface
affected
• Disease activity
• Response of previous therapies
• Impact of disease on the person
![Page 15: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/15.jpg)
• Secondary Syphilis
• Lichen Planus
• Pityriasis Rubra Pilaris
• Seborrheic Dermatitis
![Page 16: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/16.jpg)
Three types of treatment, also called 1-2-3 approach
• Topical treatment
• Systemic treatment
• Photo therapy treatment
![Page 17: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/17.jpg)
Coal tar application over lesions* Icthyol salicylic ointment-6%ichthyol+35%salicylic acid used.
* Goeckermans regime - daily application of tar, UVR exposure
Dithramol * 0.1 to 1 %conc used * ointment based anthralin applied to lesions n washed off after
30 min to 2hr application time
Topical Treatment
![Page 18: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/18.jpg)
Calapotrial
* It is a Vitamin d3 analogue * Effective 4 both short n long term treatment of psoriasis * Mainly used 4 resistant localized psoriatic patches * Highly expensive
Tazarotene
* 0.1% to 0.05%gel * Modified vitamin A molecule formulated as topical agent * Mainly used for treatment of nail psoriasis
Topical steriods
* Mild to moderate psoriasis * Clobetasol propionate,halobetasol used * Reduces the itching n redness
Topical Treatment
![Page 19: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/19.jpg)
Systemic treatment
• Methotrescale
* Antometabolie,folic acid antagonist * Inhibits mitosis * Drug of choice in psoriatic arthropathy * Dose : 7.5mg to 15mg/week
• Puva Therapy
* Psoarlen,photosensitising agent * Pro drug that upon oral administration is distributed through out the body,bt is only activated by UVR in those sites that are exposed to uva * Taken on alternate days * Puva sol-psoralen +exposure to sunlight * Patient need to wear UVR resistant glasses for 24 hrs after therapy
![Page 20: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/20.jpg)
•Oral retinoids
* Especially for pustular patients * 0.5mg to 1mg/kg body wt
• Cyclosporine * Immunosuppressive * Dose 2.5 to 5 mg/kg body wt per day
•Biologicals * Infliximab, etanercept * Other drugs that can b used are hydroxy urea and sulfasalazine
Systemic treatment
![Page 21: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/21.jpg)
•Hydroxyurea
•Antibiotics * Doxycycline * Polymorphonuclear chemotaxis
•Rotating treatment * All modalities of Rx used for wide spread severe patients * Have side effects when used for long time * So switch the medicine in 1-2 years
Systemic treatment
![Page 22: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/22.jpg)
• UVB photo therapy
• PUVA (ultraviolet A (UVA)
• Photo therapy treatment
![Page 23: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/23.jpg)
•Psoriasis is a lifelong condition.
•Many of the most effective agents used to treat severe
psoriasis carry an increased risk of significant morbidity
including skin cancers, lymphoma and liver disease.
•Controlling the signs and symptoms typically requires
lifelong therapy.
![Page 24: * Chronic papulosqamous disease of unknown etiology characterised by multiple erythematous papules & plaques with micaceous scales mainly involving extensor](https://reader035.vdocument.in/reader035/viewer/2022062314/56649dbd5503460f94aaf5bb/html5/thumbnails/24.jpg)
Thank you